Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer

키워드

참고문헌 (39)

1. Li X, "Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy", BMC Cancer, 17, pp.227~ (2017)[DOI]
2. Siegel RL, "Cancer statistics, 2016", CA Cancer J Clin, 66, pp.7~30 (2016)[DOI]
3. Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)[DOI]
4. Hoecht S, "Treatment of rectal cancer", N Engl J Med, 355, pp.2486~ (2006)[DOI]
5. Beck B, "Unravelling cancer stem cell potential", Nat Rev Cancer, 13, pp.727~738 (2013)[DOI]
6. Cao L, "OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma", BMC Cancer, 13, pp.82~ (2013)[DOI]
7. Zhou Xi, "Over-Expression of Oct4 in Human Esophageal Squamous Cell Carcinoma", Molecules and Cells, 32(1), pp.39~45 (2011), 한국분자세포생물학회
8. Lin J, "MiR-26b", KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4, 2015, pp.6, 23793~23806
9. Jaenisch R, "Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming", Cell, 132, pp.567~582 (2008)[DOI]
10. Neumann J, "SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer", BMC Cancer, 11, pp.518~ (2011)[DOI]
11. Lessey BA, "Aberrant integrin expression in the endometrium of women with endometriosis", J Clin Endocrinol Metab, 79, pp.643~649 (1994)
12. Kashyap V, "Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs", Stem Cells Dev, 18, pp.1093~1108 (2009)[DOI]
13. Wang YD, "OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b", BAK1 pathway, 2013, pp.4, e760~
14. Tang YA, "Global Oct4 target gene analysis reveals novel downstream PTEN and TNC genes required for drug-resistance and metastasis in lung cancer", Nucleic Acids Res, 43, pp.1593~1608 (2015)[DOI]
15. Wu Y, "Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells", Cancer, 117, pp.3989~3998 (2011)[DOI]
16. Yu B, "Expressions of stem cell transcription factors Nanog and Oct4 in renal cell carcinoma tissues and clinical significance", Artif Cells Nanomed Biotechnol, 44, pp.1818~1823 (2016)[DOI]
17. Li X, "Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer", Int J Mol Sci, 13, pp.7663~7675 (2012)[DOI]
18. Li C, "OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma", PLoS One, 7, pp.e49693~ (2012)[DOI]
19. Matsuoka J, "Role of the stemness factors sox2, oct3", 4, and nanog in gastric carcinoma, 2012, pp.174, 130~135
20. Atlasi Y, "OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer", Int J Cancer, 120, pp.1598~1602 (2007)[DOI]
21. Chiou SH, "Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma", Clin Cancer Res, 14, pp.4085~4095 (2008)[DOI]
22. Shen L, "High expression of SOX2 and OCT4 indicates radiation resistance and an independent negative prognosis in cervical squamous cell carcinoma", J Histochem Cytochem, 62, pp.499~509 (2014)[DOI]
23. Linn DE, "A role for OCT4 in tumor initiation of drug-resistant prostate cancer cells", Genes Cancer, 1, pp.908~916 (2010)[DOI]
24. Li B, "Overexpression of OCT4 is associated with gefitinib resistance in non-small cell lung cancer", Oncotarget, 7, pp.77342~77347 (2016)
25. Sullivan JP, "Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy", Cancer Metastasis Rev, 29, pp.61~72 (2010)[DOI]
26. Li W, "Dual inhibiting OCT4 and AKT potently suppresses the propagation of human cancer cells", Sci Rep, 7, pp.46246~ (2017)[DOI]
27. Emhemmed F, "Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway", Biochem Pharmacol, 89, pp.185~196 (2014)[DOI]
28. Yong X, "Helicobacter pylori upregulates Nanog and Oct4 via Wnt", <TEX>${\beta}$<, Cancer Lett, pp.2016, 374[DOI]
29. Teng HF, "Valproic acid enhances Oct4 promoter activity through PI3K", Akt, Mol Cell Endocrinol, pp.2014, 383[DOI]
30. "Rectal Cancer Treatment (PDQ(R)): Health Professional Version;PDQ Cancer Information Summaries" (2002), National Cancer Institute
31. Al-Marzoqee FY, "Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis", Int J Oncol, 41, pp.1733~1743 (2012)[DOI]
32. Wen Y, "SOX2 is required to maintain cancer stem cells in ovarian cancer", Cancer Sci, 108, pp.719~731 (2017)[DOI]
33. Xiao L, "Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide- induced acute uterine injury and intrauterine adhesions", Reprod Biol Endocrinol, 15, pp.14~ (2017)[DOI]
34. Piva M, "Sox2 promotes tamoxifen resistance in breast cancer cells", EMBO Mol Med, 6, pp.66~79 (2014)[DOI]
35. Bass AJ, "SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas", Nat Genet, 41, pp.1238~1242 (2009)[DOI]
36. Sodja E, "The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer", Radiol Oncol, 50, pp.188~196 (2016)
37. Yamawaki K, "Sox2-dependent inhibition of p21 is associated with poor prognosis of endometrial cancer", Cancer Sci, 108, pp.632~640 (2017)[DOI]
38. Velcheti V, "High SOX2 levels predict better outcome in non-small cell lung carcinomas", PLoS One, 8, pp.e61427~ (2013)[DOI]
39. Sholl LM, "Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma", Am J Surg Pathol, 34, pp.1193~1198 (2010)[DOI]

관련 논문AI추천